COLLABORATIONS

HOW SLEEP NUMBER IS WORKING WITH MAYO CLINIC

In 2020, we announced a collaboration with Mayo Clinic. Our goal is to further sleep science and improve health care quality and clinical outcomes.

 

  • Through this collaboration, Sleep Number aims to further enhance products and provide consumers with science- based ways to achieve better sleep – and health – at home.

 

  • Leveraging our proprietary data, our collaboration is intended to allow Mayo Clinic researchers to deepen their understanding of sleep and sleep disorders, and their relationship with health and disease.

 

  • Sleep Number is funding several studies, including research to explore Excessive Daytime Sleepiness and its cardiovascular implications.

 

  • Through our collaboration, Sleep Number is also planning to fund Mayo Clinic research projects to support underserved communities:

 

        • Prevalence of disordered sleep (sleep apnea, insomnia, and short sleep) in patients with Somali heritage and the implications for cardiovascular risk.

 

        • Relationship between disrupted sleep and markers of aging (telomeres, senescence, chronologic EKG based on Artificial Intelligence).

 

 

PREVIOUS MAYO CLINIC RESEARCH

November 2023: AAS Presentation  

Blood Pressure and Heart Rate Response to Orthostasis in Somali Americans: Race and Sex Differences


October 2023: Chest

A Prospective Pilot Study of OSA among Somali Americans in the Midwest

May 2023: Frontiers

Sex-specific associations between daytime sleepiness, chronic disease and mortality in OSA


April 2023: APS Presentation

Nocturnal Blood Pressure and Heart Rate in Somali Americans: Implications for Cardiovascular Risk


December 2022: R01 Abstract

Disrupted Sleep in Somali Americans – Implications for Hypertension Risk

November 2022: Sleep Medicine Reviews

Exosomes, sleep apnea, and cardiovascular disease: Implications for pathogenesis and promises for prevention


November 2022: AAS Presentation

Orthostatic Responses and Excessive Daytime Sleepiness

October 2022: HEART

Excessive Daytime Sleepiness: An Emerging Marker of Cardiovascular Risk

July 2022: SLEEP

Implications of sympathetic activation for objective vs. self-reported daytime sleepiness in OSA

December 2021: Nature & Science of Sleep 

Excessive Daytime Sleepiness and Cardiovascular Mortality in US Adults: A NHANES 2005-2005 Follow-Up Study

May 2021: Candian Journal of Cardiology 

OSA as a Cardiovascular Risk Factor - Beyond CPAP